Loading clinical trials...
Loading clinical trials...
Two key methods of GVHD prevention in allogeneic HSCT have a number of limitations: ex vivo T depletion is associated with an excess of infectious complications, and pharmacological immunosuppression ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
NCT04050280 · Acute Myeloid Leukemia, Adult, Acute Myeloid Leukemia Recurrent, and more
NCT03063203 · Acute Myeloid Leukemia, Acute Myeloid Leukemia, Relapsed, Adult
NCT03985007 · Acute Myeloid Leukemia, Relapsed, Adult
National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198
Moscow
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions